2024 JP Morgan Healthcare Conference
BRUKER'S TRANSFORMATION INTO A FAST GROWTH COMPANY
Project Accelerate & Operational Excellence: Disciplined entrepreneurialism at work
Bruker Management Process and culture of Disciplined Entrepreneurialism drive profitable growth
Successful transformation into a fast growth company:
On track for three consecutive years of >10% organic revenue growth in 2021-2023
Goal to grow revenue organically 200-300 bps above market in 2024-2026
Goal of >10% non-GAAP EPS CAGR in 2024-2026, with continued high RolC
●
●
●
BRUKER
Investing in large secular opportunities Proteomics/Multiomics and Spatial/Single-Cell Biology
Bruker is an Emerging Leader of the Post-Genomic Era in the life-science tools (LST/Dx) sector
2023 Bruker
Innovation with Integrity |
January 8, 2024
I
12View entire presentation